MARIETTA, Ga., May 05, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced the publication of its health economics data for reconstruction of cutaneous wounds with EPIFIX® (Dehydrated Human Amnion Chorion Membrane, or DHACM) following Mohs surgery. The study has been published in the May 2025 issue of Journal of Drugs in Dermatology: “Placental allograft reconstruction of cutaneous wounds following Mohs surgery: a propensity score-matched comparative cost-e ...

SALT LAKE CITY, May 05, 2025 (GLOBE NEWSWIRE) -- Diamond Lake Minerals, Inc. (OTC: DLMI), a multi-strategy operating company focused on digital assets and SEC-registered security tokens, today announced the formation of its Advanced Materials & IP Division (AMIPD)-a wholly integrated division within DLMI that will spearhead the Company’s exploration into frontier intellectual property over the coming decade. AMIPD functions as a direct extension of DLMI; all IP and activity under AMIPD are wholly owned and ...

LOS ANGELES, May 05, 2025 (GLOBE NEWSWIRE) -- Hanmi Financial Corporation (NASDAQ: HAFC, or “Hanmi”), the parent company of Hanmi Bank (the “Bank”), today announced its participation in the D.A. Davidson 27th Annual Financial Institutions Conference on Tuesday, May 6 and Wednesday, May 7, 2025, in Scottsdale, AZ. Bonnie Lee, President and Chief Executive Officer, and Ron Santarosa, Chief Financial Officer, will host one-on-one and small group meetings during the conference. A copy of the presentation being ...

COPENHAGEN, Denmark, May 05, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced it will share the latest data from its hypoparathyroidism, achondroplasia, and growth hormone deficiency (GHD) programs during ESPE & ESE 2025, the joint congress of the European Society for Paediatric Endocrinology (ESPE) and the European Society of Endocrinology (ESE) being held May 10-13, 2025, in Copenhagen. Four oral presentations will feature Ascendis clinical trial results, including 4-year effica ...

COSM is internationally recognized as one of the foremost meetings globally for the otolaryngology-head and neck surgery community. By convening multiple leading otolaryngology societies, the conference serves as a comprehensive academic platform dedicated to disseminating cutting-edge research, delivering advanced clinical education, and fostering collaboration among specialists to enhance patient care in head and neck medicine and surgery. Baird Medical's participation in COSM highlights the expanding app ...

RESTON, Va., May 05, 2025 (GLOBE NEWSWIRE) -- Comscore (NASDAQ: SCOR), a global leader in measuring and analyzing consumer behaviors, today announced a new solution to address the inventory quality challenges facing advertisers. Comscore Certified Deal IDs, initially available through Magnite's (NASDAQ: MGNI) supply-side platform (SSP), leverage Comscore's trusted content measurement rankings to offer advertisers a reliable path to high-quality programmatic inventory, enabling more effective campaign perfor ...

-- Majority of individuals polled reported tardive dyskinesia negatively impacts their day-to-day ability to function, including individuals living with mild or moderate uncontrolled movements1 SAN DIEGO, May 5, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the release of findings from a new survey conducted by The Harris Poll highlighting the profound negative impact of tardive dyskinesia on patients and reinforcing the need for routine screening, earlier diagnosis and tr ...

NEW YORK, May 5, 2025 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating Inhibikase Therapeutics, Inc. (NASDAQ: IKT) on behalf of the company's shareholders. The investigation seeks to determine whether Inhibikase Therapeutics's directors breached their fiduciary duties in connection with recent corporate actions.If you are a shareholder of Inhibikase Therapeutics, Inc. and are interested in obtaining additional information about your rights and options, please visit us at: https://p ...

WOODBURY, NY, May 05, 2025 (GLOBE NEWSWIRE) -- Research Frontiers Inc. (Nasdaq: REFR) announced today that it will release its first quarter 2025 financial results on Thursday, May 8, 2025. Research Frontiers will host a conference call at 4:30 p.m. Eastern Time on Thursday, May 8, 2025 to discuss its first quarter 2025 financial and operating results, as well as recent developments. Who: Joseph M. Harary, President & CEODate/Time: Thursday, May 8, 2025, 4:30 PM ETDial-in Information: 1-888-334-5785Conferen ...

Hanesbrands Inc. (HBI) is likely to register a top-line decline when it reports first-quarter 2025 earnings on May 8. The Zacks Consensus Estimate for revenues is pegged at $765.8 million, suggesting a decrease of 33.8% from the prior-year quarter's level.The consensus mark for first-quarter earnings has remained unchanged in the past 30 days at 3 cents per share, indicating a significant improvement from a loss of 2 cents per share in the year-ago quarter. HBI has a trailing four-quarter earnings surprise ...